PALO

MEGA MATRIX CORP. Provides Business Update

Retrieved on: 
Monday, March 18, 2024
MPU, Growth, Acquisition, Bank statement, App Store (iOS/iPadOS), PALO, GAAP

PALO ALTO, Calif., March 18, 2024 (GLOBE NEWSWIRE) -- Mega Matrix Corp. ("MPU" or the "Company") (NYSE American: MPU), today provided a business update.

Key Points: 
  • PALO ALTO, Calif., March 18, 2024 (GLOBE NEWSWIRE) -- Mega Matrix Corp. ("MPU" or the "Company") (NYSE American: MPU), today provided a business update.
  • During the first quarter of 2024, the company ceased its crypto-related business operation and is concentrating on its short drama streaming services.
  • On January 20, 2024, FlexTV's rose to 8th position in the Apple App Store Entertainment Top Charts (Free Apps, U.S.).
  • Mr. Yucheng Hu, CEO of Mega Matrix Corp. said, “In Q4 of 2023, Mega Matrix Corp. strategically transitioned away from the cryptocurrency sector, redirecting our focus towards FlexTV, our short drama platform designed for the vertical screen era.

Scilex Holding Company Provides Responses to Product Composition Questions Related to its ELYXYB® Patent in Canada for a New Drug Submission Under Review by Health Canada for the Approval of ELYXYB® for Acute Treatment of Migraine With or Without Aura in

Retrieved on: 
Monday, March 18, 2024
Neurology, Headache, NDS, Patient, Contraindication, Nonsteroidal anti-inflammatory drug, Chronic pain, Migraine, Health Canada, Chemical patent, PALO, OPML, Patent, Therapy, FDA

ELYXYB® (celecoxib oral solution) is in the same class of agents, is fast acting, and has the potential to have the lowest gastrointestinal (GI) side effects of all NSAIDs.3

Key Points: 
  • ELYXYB® (celecoxib oral solution) is in the same class of agents, is fast acting, and has the potential to have the lowest gastrointestinal (GI) side effects of all NSAIDs.3
    The anticipated timeline for approval in Canada is approximately 12 months depending on review cycles and information requests by Health Canada.
  • ELYXYB®’s product profile mapped with a high degree of certainty to these stated unmet needs.
  • For more information on ZTlido® including Full Prescribing Information, refer to www.ztlido.com .
  • For more information on Gloperba®, including Full Prescribing Information, refer to www.gloperba.com .

Scilex Holding Announces Issuance of Halal Certification for its ZTlido® product by Circle H International, Inc.

Retrieved on: 
Friday, March 15, 2024
Certification, Islam, Muslims, Halal, Chronic pain, Lidocaine, Council, PALO, MENA, FDA, Nursing

The certification is an important prerequisite for health care and covers health and wellness as well as non-addictive pain management products.

Key Points: 
  • The certification is an important prerequisite for health care and covers health and wellness as well as non-addictive pain management products.
  • The Halal certification was issued under the authority of Circle H International, Inc. (“Circle H”) and offers the Company the opportunity to provide ZTlido to Islamic markets globally.
  • Circle H issued the Halal Certification based on the global standards promulgated by its esteemed Circle H Sharia Advisory Council (the “Council”).
  • Circle H and the Council are recognized and supported by prominent governmental and non-governmental organizations and Islamic universities.

Scilex Holding Company’s Wholly Owned Subsidiary, Scilex Pharmaceuticals Inc., Entered into a Definitive Mutual Release and Settlement Agreement with Virpax Pharmaceuticals, Inc. Relating to the Previously Announced Term Sheet with Virpax in Respect of Su

Retrieved on: 
Friday, March 15, 2024
Bankruptcy, Plaintiff, Action, Sale, Chronic pain, United States bankruptcy court, Settlement, PALO, Court, Nursing

The Definitive Settlement Agreement relates to the term sheet previously announced by Scilex on February 26, 2024, regarding a mutual release and settlement agreement between Scilex Pharma, Sorrento and Virpax in respect of the action (the “Action”) filed by Scilex Pharma and Sorrento (together, the “Plaintiffs”) against Anthony Mack, former President of Scilex Pharma and Virpax, a company founded and then headed by Mr. Mack.

Key Points: 
  • The Definitive Settlement Agreement relates to the term sheet previously announced by Scilex on February 26, 2024, regarding a mutual release and settlement agreement between Scilex Pharma, Sorrento and Virpax in respect of the action (the “Action”) filed by Scilex Pharma and Sorrento (together, the “Plaintiffs”) against Anthony Mack, former President of Scilex Pharma and Virpax, a company founded and then headed by Mr. Mack.
  • The Plaintiffs’ release relates to claims against Virpax only, which does not affect their claims against Mr. Mack.
  • Plaintiffs’ release as to Virpax is conditioned upon Virpax’s Initial Payment.
  • For more information on Gloperba®, including Full Prescribing Information, refer to www.gloperba.com .

CommerceIQ Retail Media Insights Now Available on EMARKETER’s Industry KPIs Dashboard

Retrieved on: 
Thursday, March 14, 2024
Partnership, Marketing, PALO, Advertising, Amazon, Health, Retail media, Online shopping

Under the partnership, CommerceIQ will provide retail media data for EMARKETER’s Industry KPIs dashboard , aggregated from the 2,000-plus brands selling on Amazon and using the CommerceIQ platform.

Key Points: 
  • Under the partnership, CommerceIQ will provide retail media data for EMARKETER’s Industry KPIs dashboard , aggregated from the 2,000-plus brands selling on Amazon and using the CommerceIQ platform.
  • “EMARKETER has cemented itself as a go-to resource for business insights, and we’re thrilled the platform now includes our industry-leading retail media intelligence,” said Guru Hariharan, founder and CEO of CommerceIQ.
  • "As brands shift budgets from traditional media to retail media, closely following key trends across ecommerce sites builds a foundation of success.
  • Available now, CommerceIQ’s data can be found at https://www.insiderintelligence.com/industry-kpis in both the Retail Media and E-Commerce sections.

Mega Matrix Announces short drama “Love in the Dark” Coming soon on FlexTV

Retrieved on: 
Thursday, March 14, 2024
Dark, Element, Trust, Darkness, Life, Love in the Dark, Heiress, Emotion, PALO, Family, Light, Love, Betrayal, Film industry

This new short drama is anticipated to be one of the most eagerly awaited productions of the season, thanks to its unique narrative style, nuanced emotional portrayal, and suspenseful plotline.

Key Points: 
  • This new short drama is anticipated to be one of the most eagerly awaited productions of the season, thanks to its unique narrative style, nuanced emotional portrayal, and suspenseful plotline.
  • In the story, blind heiress Emma is plunged into a whirlwind of conspiracy and conflicting emotions after her father's brutal murder.
  • Liam, her mysterious bodyguard, sweeps in to save her life and becomes her pillar of support in the dark.
  • FlexTV currently distributes content to over 100 countries worldwide, available in six languages including English, Japanese, Korean, Portuguese, Spanish, and Arabic.

180 Life Sciences Regains Full Compliance with Nasdaq Minimum Bid Price Requirement

Retrieved on: 
Thursday, March 14, 2024
Letter, PALO, Auction

PALO ALTO, Calif., March 14, 2024 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ: ATNF) (“180 Life Sciences” or the “Company”), today announced that the Company received a letter on March 13, 2024 from The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company has regained full compliance with the minimum bid price for continued listing on the Nasdaq pursuant to Nasdaq Listing Rule 5550(a)(2) (“Minimum Bid Price Requirement”).

Key Points: 
  • PALO ALTO, Calif., March 14, 2024 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ: ATNF) (“180 Life Sciences” or the “Company”), today announced that the Company received a letter on March 13, 2024 from The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company has regained full compliance with the minimum bid price for continued listing on the Nasdaq pursuant to Nasdaq Listing Rule 5550(a)(2) (“Minimum Bid Price Requirement”).
  • As indicated in the letter, Nasdaq determined that for 10 consecutive business days, the closing bid price of the Company’s common stock was at or above $1.00 per share.
  • Accordingly, the Company has regained compliance with the Minimum Bid Price Requirement.

Broadcom Delivers Industry’s First 51.2-Tbps Co-Packaged Optics Ethernet Switch Platform for Scalable AI Systems

Retrieved on: 
Thursday, March 14, 2024
Cloud, Logic, HBM, Optics, CMOS, Bailly, Application-specific integrated circuit, CPO, Partnership, Broadcom Inc., Copper, GVP, Graphics processing unit, PALO, Investment, Exhibition, PHY, ByteDance, TBPS, AVGO, Silicon photonics, Silicon, Video game

The product integrates eight silicon photonics based 6.4-Tbps optical engines with Broadcom’s best-in-class StrataXGS® Tomahawk®5 switch chip.

Key Points: 
  • The product integrates eight silicon photonics based 6.4-Tbps optical engines with Broadcom’s best-in-class StrataXGS® Tomahawk®5 switch chip.
  • The optical interconnect is critical for both front-end and back-end networks in large scale generative AI clusters.
  • Today, pluggable optical transceivers consume approximately 50% of system power and constitute more than 50% of the cost of a traditional switch system.
  • “Our partnership with Broadcom to design systems with highly integrated co-packaged optics will enable a more power efficient future network.

Broadcom Extends Technology and Volume Leadership on AI Optical Components

Retrieved on: 
Wednesday, March 13, 2024
Optics, Partnership, Fibre Channel, HPC, Artificial intelligence, AI, PCI Express, EML, Graphics processing unit, PALO, Exhibition, CW, Machine learning, CMO, NVIDIA, AVGO, Internet service provider

Broadcom’s state-of-the-art optics technologies facilitate high speed interconnects for front-end and back-end networks of large-scale generative AI compute clusters.

Key Points: 
  • Broadcom’s state-of-the-art optics technologies facilitate high speed interconnects for front-end and back-end networks of large-scale generative AI compute clusters.
  • VCSEL and EML technologies play a crucial role in enabling high-speed interconnects for AI and ML systems.
  • “Generative AI has unleashed a network transformation necessitating an order of magnitude increase in high-speed optical links compared to standard network requirements,” said Near Margalit, Ph.
  • Broadcom is once again among the first suppliers of components enabling the next generation of optical transceivers.”
    “Enterprises continue to demand larger AI clusters, elevating the importance of cutting-edge optical interconnects,” said Craig Thompson, vice president of LinkX products at NVIDIA.

Hatch Introduces Personalized Feature Bringing Bedtime to Those Who Can't Be There

Retrieved on: 
Thursday, April 4, 2024
Mindfulness, Friends, Entrepreneurship, Mum, Hearing, Journal, Sleep, Child, Behavior, PALO, The Journal of Pediatrics, Family, Parent, Human, Toy

PALO ALTO, Calif., April 4, 2024 /PRNewswire/ -- Hatch, a sleep wellness company that teaches the whole family better sleep habits, is launching a new premium feature for its baby and kids' Rest devices that can bring family and friends closer together, no matter the distance.

Key Points: 
  • "We know that raising a child takes a village, and when that village isn't physically present it can feel isolating," says Ann Crady Weiss, Co-Founder and CEO of Hatch.
  • "Tuck-Ins can create a meaningful, sleep-inducing bedtime routine for your little one.
  • As we celebrate our 10-year anniversary, we are excited to expand our unique feature and premium Hatch+ content offerings to benefit the whole family, and we believe Tuck-Ins is a prime example of this."
  • "Tuck-Ins by You has become a bedtime special - it's like Mum is really there reading to my kids!"